Skip to main content
logo
MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
16.29
-0.06 (-0.37%)
Aug 18, 2026, 1:12 PM EDT - Market open

MLTX Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,3869413,4153,620409-
Market Cap Growth
-59.86%-72.45%-5.66%784.47%--
Enterprise Value
9516382,9323,189353-
Last Close Price
16.3513.1854.1560.3910.509.89

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
3.193.097.537.055.95-
P/TBV Ratio
3.253.097.647.308.37-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.240.250.010.010.00-1.29
Net Debt / Equity Ratio
-1.02-1.04-0.98-0.99-1.04-0.60
Net Debt / EBITDA Ratio
1.641.313.149.441.11-0.20
Net Debt / FCF Ratio
1.931.623.8011.781.29-0.16
Quick Ratio
11.988.7720.0751.389.440.39
Current Ratio
12.569.2721.1151.599.980.46
Return on Equity (ROE)
-67.47%-60.78%-25.08%-15.14%-225.86%-
Return on Assets (ROA)
-32.44%-33.92%-17.81%-11.21%-93.99%-
Return on Capital Employed (ROCE)
-50.80%-64.60%-31.40%-10.50%-94.00%300.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-18.95%-24.16%-3.48%-1.00%-12.21%-
FCF Yield
-16.18%-20.84%-3.43%-1.19%-13.66%-
Buyback Yield / Dilution
-9.53%-2.54%-27.99%-67.30%-274.47%-
SEC Filings: 10-K · 10-Q